E O Billington1, S H Phang1, D B Gregson2, J D D Pitout2, T Ross2, D L Church3, K B Laupland4, M D Parkins5. 1. Department of Medicine. 2. Microbiology and Infectious Diseases; Calgary Laboratory Services, Calgary, AB CANADA. 3. Department of Medicine; Microbiology and Infectious Diseases; Calgary Laboratory Services, Calgary, AB CANADA. 4. Department of Medicine; Community Health Sciences; Critical Care Medicine, The University of Calgary, Calgary, AB CANADA. 5. Department of Medicine; Microbiology and Infectious Diseases. Electronic address: mdparkin@ucalgary.ca.
Abstract
BACKGROUND: Enterococci are a clinically significant cause of bloodstream infections (BSI), particularly in the nosocomial setting. The purpose of this study was to characterize the incidence, risk factors for acquisition, microbiological characteristics and mortality of enterococcal BSI within the well-defined population of a large Canadian health region. METHODS: Surveillance for all episodes of enterococcal BSI occurring among residents of the Calgary Health Zone (population 1.2 million) between 2000 and 2008 was conducted using an electronic surveillance system. Clinical features, microbiology, and outcomes were obtained. RESULTS: A total of 710 incident episodes of enterococcal BSI were identified for an annual incidence of 6.9 episodes per 100,000; the incidences of E. faecalis and E. faecium BSI were 4.5, and 1.6 per 100,000, respectively. Enterococcus faecalis infections were associated with a urinary focus, genitourinary malignancy, and abnormal genitourinary anatomy. E. faecium infections were associated with a gastrointestinal focus. Resistance to ampicillin, vancomycin and ciprofloxacin was higher in E. faecium infection. The overall case fatality rate was 22.8%, and was higher for E. faecium infection. CONCLUSIONS: This is the second population-based study to assess the risk factors for enterococcal BSI and compare the characteristics of infection with E. faecalis and E. faecium. Results suggest that BSI with E. faecalis and E. faecium should be regarded as two clinically different entities with unique sets of risk factors and microbiologic characteristics.
BACKGROUND: Enterococci are a clinically significant cause of bloodstream infections (BSI), particularly in the nosocomial setting. The purpose of this study was to characterize the incidence, risk factors for acquisition, microbiological characteristics and mortality of enterococcal BSI within the well-defined population of a large Canadian health region. METHODS: Surveillance for all episodes of enterococcal BSI occurring among residents of the Calgary Health Zone (population 1.2 million) between 2000 and 2008 was conducted using an electronic surveillance system. Clinical features, microbiology, and outcomes were obtained. RESULTS: A total of 710 incident episodes of enterococcal BSI were identified for an annual incidence of 6.9 episodes per 100,000; the incidences of E. faecalis and E. faecium BSI were 4.5, and 1.6 per 100,000, respectively. Enterococcus faecalis infections were associated with a urinary focus, genitourinary malignancy, and abnormal genitourinary anatomy. E. faecium infections were associated with a gastrointestinal focus. Resistance to ampicillin, vancomycin and ciprofloxacin was higher in E. faeciuminfection. The overall case fatality rate was 22.8%, and was higher for E. faeciuminfection. CONCLUSIONS: This is the second population-based study to assess the risk factors for enterococcal BSI and compare the characteristics of infection with E. faecalis and E. faecium. Results suggest that BSI with E. faecalis and E. faecium should be regarded as two clinically different entities with unique sets of risk factors and microbiologic characteristics.
Authors: Daria Van Tyne; Abigail L Manson; Mark M Huycke; John Karanicolas; Ashlee M Earl; Michael S Gilmore Journal: Sci Transl Med Date: 2019-04-10 Impact factor: 17.956
Authors: Kathleen M Ross; Jason S Mehr; Rebecca D Greeley; Lindsay A Montoya; Prathit A Kulkarni; Sonya Frontin; Trevor J Weigle; Helen Giles; Barbara E Montana Journal: J Am Dent Assoc Date: 2018-02-02 Impact factor: 3.634
Authors: Jordan R Smith; Katie E Barber; Animesh Raut; Mostafa Aboutaleb; George Sakoulas; Michael J Rybak Journal: J Antimicrob Chemother Date: 2015-02-01 Impact factor: 5.790
Authors: Evan J Zasowski; Kimberly C Claeys; Abdalhamid M Lagnf; Susan L Davis; Michael J Rybak Journal: Clin Infect Dis Date: 2016-03-03 Impact factor: 9.079